Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology
Journal title: Canadian Journal of Biotechnology
Authors:
Subject(s): Biotechnology